Trial Profile
A Prospective, Randomized, Double-blind Crossover Study Comparing 0.15 g/L rhBSSL Added to Pasteurized Breast Milk Versus Placebo During One Week of Treatment in Preterm Infants Born Before Week 32 of Gestational Age
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2014
Price :
$35
*
At a glance
- Drugs Bucelipase alfa (Primary)
- Indications Malabsorption syndromes
- Focus Therapeutic Use
- Sponsors Swedish Orphan Biovitrum
- 03 Jun 2014 New trial record